EDAP TMS S.A. (FOCL) - Net Assets

Latest as of June 2026: $-3.23 Million USD

Based on the latest financial reports, EDAP TMS S.A. (FOCL) has net assets worth $-3.23 Million USD as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($74.55 Million) and total liabilities ($77.77 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See FOCL net asset quality score to measure how much of total assets are equity-financed.

Key Net Assets Metrics

Metric Value
Current Net Assets $-3.23 Million
% of Total Assets -4.33%
Annual Growth Rate -1.41%
5-Year Change -65.9%
10-Year Change -25.45%
Growth Volatility 32.04

EDAP TMS S.A. - Net Assets Trend (2006–2025)

This chart illustrates how EDAP TMS S.A.'s net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see how much is EDAP TMS S.A. worth.

Annual Net Assets for EDAP TMS S.A. (2006–2025)

The table below shows the annual net assets of EDAP TMS S.A. from 2006 to 2025. Also explore net asset growth rate of EDAP TMS S.A. to track the company's year-over-year net asset growth rate.

Year Net Assets Change
2025-12-31 $19.41 Million -54.16%
2024-12-31 $42.35 Million -32.65%
2023-12-31 $62.88 Million -17.75%
2022-12-31 $76.45 Million +34.31%
2021-12-31 $56.92 Million +70.13%
2020-12-31 $33.46 Million +4.84%
2019-12-31 $31.91 Million +7.36%
2018-12-31 $29.73 Million -5.51%
2017-12-31 $31.46 Million +20.81%
2016-12-31 $26.04 Million +63.43%
2015-12-31 $15.93 Million -13.83%
2014-12-31 $18.49 Million +44.54%
2013-12-31 $12.79 Million +18.90%
2012-12-31 $10.76 Million -4.89%
2011-12-31 $11.31 Million -5.26%
2010-12-31 $11.94 Million -33.84%
2009-12-31 $18.05 Million -24.47%
2008-12-31 $23.90 Million +12.73%
2007-12-31 $21.20 Million -16.71%
2006-12-31 $25.45 Million --

Equity Component Analysis

This analysis shows how different components contribute to EDAP TMS S.A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 12487762800.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Common Stock $6.07 Million 31.27%
Other Comprehensive Income $-8.34 Million -42.95%
Other Components $150.29 Million 774.20%
Total Equity $19.41 Million 100.00%

EDAP TMS S.A. Competitors by Market Cap

The table below lists competitors of EDAP TMS S.A. ranked by their market capitalization.

Company Market Cap
BBMG Corporation
F:9BM
$153.12 Million
St.Shine Optical Co Ltd
TWO:1565
$153.12 Million
Chant Sincere Co Ltd
TW:6205
$153.13 Million
Mega Uranium Ltd.
TO:MGA
$153.14 Million
Brazil Potash Corp.
NYSE:GRO
$153.11 Million
Atp Ticari Bilgisayar Agi ve Elektrik Guc Kaynaklari Uretim Pazarlama ve Ticaret
IS:ATATP
$153.10 Million
JIUMAOJIU INTL HLDGS LTD
F:3YU
$153.05 Million
Amrutanjan Health Care Limited
NSE:AMRUTANJAN
$153.02 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in EDAP TMS S.A.'s equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 42,347,808 to 19,413,000, a change of -22,934,808 (-54.2%).
  • Net loss of 29,336,493 reduced equity.
  • Other comprehensive income decreased equity by 3,269,263.
  • Other factors increased equity by 9,670,948.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income $-29.34 Million -151.12%
Other Comprehensive Income $-3.27 Million -16.84%
Other Changes $9.67 Million +49.82%
Total Change $- -54.16%

Book Value vs Market Value Analysis

This analysis compares EDAP TMS S.A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 7.87x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has increased from 1.53x to 7.87x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2006-12-31 $2.66 $4.08 x
2007-12-31 $2.18 $4.08 x
2008-12-31 $2.47 $4.08 x
2009-12-31 $1.71 $4.08 x
2010-12-31 $0.92 $4.08 x
2011-12-31 $0.85 $4.08 x
2012-12-31 $0.61 $4.08 x
2013-12-31 $0.62 $4.08 x
2014-12-31 $0.78 $4.08 x
2015-12-31 $0.63 $4.08 x
2016-12-31 $0.88 $4.08 x
2017-12-31 $1.04 $4.08 x
2018-12-31 $0.98 $4.08 x
2019-12-31 $1.04 $4.08 x
2020-12-31 $1.10 $4.08 x
2021-12-31 $1.76 $4.08 x
2022-12-31 $2.22 $4.08 x
2023-12-31 $1.70 $4.08 x
2024-12-31 $1.14 $4.08 x
2025-12-31 $0.52 $4.08 x

Capital Efficiency Dashboard

This dashboard shows how efficiently EDAP TMS S.A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -151.12%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -41.47%
  • • Asset Turnover: 0.90x
  • • Equity Multiplier: 4.07x
  • Recent ROE (-151.12%) is below the historical average (-31.96%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2006 -17.06% -17.01% 0.60x 1.68x $-6.89 Million
2007 -35.31% -24.45% 0.47x 3.10x $-9.61 Million
2008 9.82% 6.99% 0.55x 2.55x $-42.86K
2009 -60.06% -31.27% 0.60x 3.21x $-12.64 Million
2010 -140.94% -54.81% 0.64x 4.04x $-18.02 Million
2011 -11.61% -4.21% 0.75x 3.70x $-2.44 Million
2012 -89.74% -28.73% 0.84x 3.73x $-10.73 Million
2013 -52.21% -20.85% 0.86x 2.89x $-7.96 Million
2014 -3.71% -1.91% 0.91x 2.12x $-2.51 Million
2015 -11.79% -5.17% 0.85x 2.67x $-3.42 Million
2016 16.48% 10.79% 0.80x 1.91x $1.67 Million
2017 -2.54% -1.91% 0.72x 1.86x $-3.79 Million
2018 -1.40% -0.86% 0.83x 1.95x $-3.25 Million
2019 5.51% 3.37% 0.84x 1.94x $-1.38 Million
2020 -6.05% -4.09% 0.70x 2.10x $-5.15 Million
2021 1.45% 1.59% 0.59x 1.54x $-4.86 Million
2022 -4.03% -5.32% 0.54x 1.41x $-10.73 Million
2023 -36.41% -35.05% 0.65x 1.61x $-29.18 Million
2024 -48.58% -29.66% 0.78x 2.10x $-24.81 Million
2025 -151.12% -41.47% 0.90x 4.07x $-31.28 Million

Industry Comparison

This section compares EDAP TMS S.A.'s net assets metrics with peer companies in the Medical Distribution industry.

Industry Context

  • Industry: Medical Distribution
  • Average net assets among peers: $1,127,006,608
  • Average return on equity (ROE) among peers: 12.47%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
EDAP TMS S.A. (FOCL) $-3.23 Million -17.06% N/A $153.11 Million
Accendra Health Inc (ACH) $314.40 Million 8.91% 1.75x $84.85 Million
Akso Health Group ADR (AHG) $14.01 Million 25.25% 0.60x $807.33 Million
Cardinal Health Inc (CAH) $1.79 Billion 34.06% 23.78x $43.01 Billion
Cencora Inc. (COR) $3.32 Billion 10.40% 2.38x $50.53 Billion
Cosmos Health Inc. (COSM) $-6.46 Million 0.00% 0.00x $14.53 Million
EDAP TMS SA (EDAP) $34.78 Million 33.77% 0.45x $154.80 Million
Empro Group Inc. Ordinary shares (EMPG) $741.21K -42.90% 4.10x $143.05 Million
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) $4.25 Million 31.26% 1.04x $4.78 Million
Henry Schein Inc (HSIC) $4.67 Billion 11.52% 0.84x $7.86 Billion

About EDAP TMS S.A.

NASDAQ:FOCL USA Medical Distribution
Market Cap
$153.11 Million
Market Cap Rank
#17650 Global
#4169 in USA
Share Price
$4.08
Change (1 day)
-0.73%
52-Week Range
$4.08 - $6.34
All Time High
$6.34
About

EDAP TMS S.A., doing business as FocalTherics, operates as a medical technology company that develops, manufactures, markets, and sells non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications.… Read more